期刊文献+

老年患者腰麻联合静脉应用右美托咪定的麻醉效应与安全性 被引量:2

Anesthetic Effect and Safety of Spinal Anesthesia Combined with Intravenous Dexmedetomidine in Elderly Patients
下载PDF
导出
摘要 目的探析老年患者腰麻联合静脉应用右美托咪定(DMT)麻醉效应以及安全性。方法择取本院于2014年8月-2016年1月期间收治的经尿道前列腺电切除术患者114例,按照患者的入院顺序,划分为对照组与研究组,每组各57例。对照组患者接受常规麻醉,研究组患者接受腰麻联合DMT静脉注射麻醉,对比两组患者的麻醉效应。结果研究组患者的最高感觉阻滞平面消退时间、术中镇静评分、低氧饱和发生率、心动过缓发生率、低血压发生率均优于对照组患者,数据组间差异具有统计学意义(P<0.05)。结论对老年患者行腰麻+DMT静脉注射麻醉,不仅具有良好的镇痛效果以及镇静效果,而且临床应用安全性较高,值得临床大面积推广。 Objective To analysze effects and safety of spinal anesthesia and intravenous application given dexmedetomidine(DMT) narcotic in elderly patients. Methods A total of 114 cases received transurethral resection from August 2014- January 2016 were divided into control group and study group of 57 cases in each group according to the order of admission, The control group patients received underwent conventional anesthesia and the study group patients received spinal anesthesia + DMT intravenous anesthesia, narcosis were compared between among them. Results The study group of patients with the highest sensory block regression time, intraoperative sedation scores, low oxygen saturation rate, the incidence of bradycardia, hypotension rate were better than those of control group with statistically significant(P0.05). Conclusion Elderly patients underwent spinal anesthesia+DMT intravenous anesthesia, not only has good analgesic and sedative effect, but higher clinical safety and is worth a wide application.
作者 冯智泉
出处 《罕少疾病杂志》 2016年第3期40-41,53,共3页 Journal of Rare and Uncommon Diseases
关键词 老年患者 腰麻 右美托咪定 麻醉效应 安全性 Elderly Patients Spinal Anesthesia Dexmedetomidine Given Narcotic Effects Security
  • 相关文献

参考文献8

二级参考文献107

  • 1芮燕,岳云.FloTrac外周动脉波形分析方法测定连续心排血量的多中心临床验证[C].2008年中华麻醉学术年会论文集.2008:135-136.
  • 2Ebert T, Hall J, Barney J, et al. The effects of increasing plasma coneentrateons of dexmedetomidine in humans [J]. Anesthesiology, 2000, 93(2): 382-394.
  • 3Fairbanks CA, Stone IS, Wilcox GL. Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis [J]. Pharmacol Ther, 2009, 123(2): 224-238.
  • 4Farag E, Argalious M, Abd-Elsayed A, et al. The use of dexmedetomidine in anesthesia and intensive care: a review [J]. Curr Phann Des, 2012, 18(38) : 6257-6265.
  • 5Ihmsen H, Sami TI. Dexmedetomidine. Pharmacokinetics and pharmacodynamics [J]. Anaesthesist, 2012, 61(12) : 1059- 1066.
  • 6Kaya FN, Yavascaoglu B, Turker G, et al. Intravenous dexme- detomidine, but not midazolam, prolongs bupivacaine spinal anes- thesia. Can J Anaesth, 2010, 57(1) : 39-45.
  • 7Hong JY, Yang SC, Ahn S, et al. Preoperative comorbidities and relationship of comorbidities with postoperative complications in patients undergoing transurethral protate resection. J Urol, 2011, 185(4) : 1374-1348.
  • 8Pollock JE, Neal JM, Liu SS, et al. Sedation during spinal anes- thesia. Anesthesiology, 2000, 93 : 728-34.
  • 9Gillian MK, Sheridan MH, Katherine A. Dexmedetomidine: a guide to its use for sedation in the US. Adis Drug Clinical, 2012, 32(8) : 561-567.
  • 10Grant SA, Breslin DS, MacLeod DB, et al. Dexmedetornidine in- fusion for sedation during fiberoptie intu-bation: a report of lhree cases. J Clin Anesth, 2004, 16(2) : 124-126.

共引文献102

同被引文献44

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部